NCT04884139 - DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: | Biotech Hunter

Enrollment

554

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

February 20, 2024

Study Completion Date

March 13, 2025

Conditions

HIV-1-infection

Interventions

DRUG

Dolutegravir/Lamivudine as a single pill

\- Dose: Dolutegravir 50mg/ Lamivudine 300 mg -Route of adminstration: oral -Schedule of administration: once a day for 96 weeks.

DRUG

Bictegravir/Emtricitabine/Tenofovir alfenamide as a single pill.

"* Dose: Bictegravir 50 mg/Emtricitabine 200 mg /Tenofovir alafenamide 25 mg~* Route of adminstration: oral~* Schedule of administration: once a day for 96 weeks."

Trial Locations (33)

19002

H. Universitario de Guadalajara, Guadalajara

25198

Hospital Universitari Arnau de Vilanova, Lleida

28922

Hospital Fundación Alcorcón, Alcorcón

03570

H. Marina Baixa, Villajoyosa

Unknown

CHUAC, A Coruña

H. de Elche, Alicante

H. de Torrecárdenas, Almería

H. de Bellvitge, Barcelona

H. de Igualada, Barcelona

H. del Mar, Barcelona

H. San Joan de Deu, Barcelona

H. Sant Creu y Sant Pau, Barcelona

H. Vall de Hebron, Barcelona

H. Juan Ramón Jimenez, Huelva

H. Infanta Leonor, Madrid

H. La Princesa, Madrid

H. Príncipe de Asturias, Madrid

H. Univ. La Paz, Madrid

H. Univ. Puerta de Hierro, Madrid

H. Costa del Sol, Marbella

H. Reina Sofía, Murcia

H. Central de Asturias, Oviedo

H. Son Espases, Palma de Mallorca

H. Son Llatzer, Palma de Mallorca

H. de Valme, Seville

H. Joan XXIII, Tarragona

H. Clínico Univ. de Valencia, Valencia

H Clinico Univ. de Valladolid, Valladolid

H. Alvaro Cunquerio, Vigo

H. Clinico Univ. Lozano Bleza, Zaragoza

03010

H. General Universitario Dr. Balmis, Alicante

08036

H. Clinic, Barcelona

08916

H. Germans Trias i Pujol, Barcelona